Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma
Authors:
- Qi ZhangQZQi Zhang
- Wenjun ChangWCWenjun Chang
- Yan DuYan Du
- Hongwei ZhangHZHongwei Zhang
- Guangwen CaoGCGuangwen Cao
- 1 September 2012
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 48 (13) , 1977-1987
Abstract
No abstract availableKeywords
Funding Information
- National Natural Scientific Foundation of China (30921006, 81025015, 91129301)
This publication has 123 references indexed in Scilit:
- Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21Gastroenterology, 2011
- Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular CarcinomaGastroenterology, 2011
- Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-cateninJournal of Hepatology, 2011
- Modeling Hepatitis B Virus X–Induced Hepatocellular Carcinoma in Mice With the Sleeping Beauty Transposon System ΔHepatology, 2010
- The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt ActivationHepatology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- NF-κB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBxOncogene, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005